MAP2 and colorectal carcinoma: As the first step, we checked neurons and glial populations in ENS by fluorescence immunohistochemistry and confocal microscopy with MAP2 and GFAP markers in healthy colon areas from untreated and OxPt-treated CRC patients (Figure 1).